What one share of Revolution Medicines holds
We are a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. We possess sophisticated structure-based drug discovery capabilities built upon deep chemical biology and cancer pharmacology know-how and innovative, proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites.
Revolution Medicines’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$8.92 |
|---|---|
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | −$6.22 |
| Cash and investments | $18.38 |
| Debt | $2.28 |
| Book value | $12.16 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $8.77 | −$21.24 | $0.65 | −$0.12 | — | −$47.16 |
| 2019 | $18.05 | −$22.33 | $0.93 | −$18.83 | — | −$46.35 |
| 2020 | $0.78 | −$2.01 | $0.05 | −$1.88 | — | $7.13 |
| 2021 | $0.40 | −$2.57 | $0.09 | −$2.11 | — | $8.13 |
| 2022 | $0.44 | −$3.08 | $0.13 | −$2.92 | — | $7.58 |
| 2023 | $0.10 | −$3.86 | $0.07 | −$3.17 | — | $11.09 |
| 2024 | $0.00 | −$3.58 | $0.06 | −$3.38 | — | $12.19 |
| 2025 | $0.00 | −$5.95 | $0.08 | −$4.81 | — | $8.28 |
Common questions about Revolution Medicines
How much does one share of Revolution Medicines earn?
Over the last 12 months, Revolution Medicines lost $8.92 for each share.
Does Revolution Medicines pay a dividend?
Revolution Medicines didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Revolution Medicines’s book value per share?
Revolution Medicines’s book value is $12.16 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Revolution Medicines have?
Each share of Revolution Medicines has $18.38 of cash and investments and $2.28 of debt, as of June 30, 2026.
What is Revolution Medicines’s free cash flow per share?
−$6.22 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Revolution Medicines bought back shares?
Revolution Medicines’s share count rose about 8171% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.